Abstract
BACKGROUND: Fibromyalgia is a chronic disorder characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, stiffness, paresthesia, and associated functional impairment. It is encountered across diverse populations and predominantly affects women. Despite advances in diagnosis and conventional management, long-term symptom control remains challenging in many patients. From an Ayurvedic perspective, the clinical presentation of fibromyalgia shows similarities with Vatika Jvara, particularly with regard to generalized pain, stiffness, fatigue, sleep disturbance, and systemic complaints.AIM:To evaluate the effect of Drakshadi Kashaya in a patient presenting with clinical features of fibromyalgia.MATERIALS AND METHODS:A single-patient case study was conducted in a 27-year-old female diagnosed with fibromyalgia based on the American College of Rheumatology (ACR) criteria. Clinical symptoms, ACR-derived Widespread Pain Index (WPI) and Symptom Severity Scale (SSS), and selected hematological parameters were assessed before and after treatment. The patient was administered Drakshadi Kashaya orally at a dose of 48 ml twice daily, one hour before food, for the treatment period. RESULTS: Following treatment, an overall reduction in fibromyalgia-related symptom severity was observed. The WPI score decreased from 5 to 4, while the SSS score decreased from 9 to 5. Improvement was also observed in musculoskeletal pain, insomnia, abdominal discomfort, appetite-related complaints, and muscle weakness. ESR decreased from 25 mm/h before treatment to 10 mm/h after treatment. The observed changes suggest a favorable clinical response to Drakshadi Kashaya. CONCLUSION: This case suggests that Drakshadi Kashaya may have beneficial effects in reducing the symptom burden associated with fibromyalgia. Its Ayurvedic properties, particularly Vata-Pitta Hara, Amahara, and Jvarahara actions, provide a rationale for its therapeutic application in presentations resembling Vatika Jvara. However, controlled clinical studies involving larger sample sizes are required to establish its efficacy and safety.